All treatments
Treatment
Kineret 100 mg/0.67 ml solution for injection in pre-filled syringe. clinical trials
2 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic exploratory (Phase II)
Efficacy and safety of anakinra in non-COVID-19 related ARDS. ESKA study.
This study is looking at a medicine called Kineret to treat a serious lung condition called ARDS in adults. We want to see if Kineret can help patients breathe on their own sooner, without needing a ventilator.
For: Acute respiratory distress syndrome (ARDS)Italy - AuthorisedTherapeutic use (Phase IV)
Biomarker-guided treatment-and-stop-strategy for recombinant IL-1receptor antagonist (anakinra) in patients with systemic Juvenile Idiopathic Arthritis
This study looks at how many injections of a medicine called anakinra (Kineret) children with systemic JIA need to stop their disease symptoms. It also checks if they stay well after stopping the medicine.
For: autoimmune disorders, joint disorders · synonym: Still's disease, systemic JIANetherlands